Q: Bew recently came alive and shot up to a 1 yr. high of .395 and closed at.38 on 3/28. Any news &/or reasons? Bought it a few years ago at .50 Please comment & advise.Txs for u usual great services & views
I bought some shares of CM a couple months ago as part of a buy and hold strategy to receive the dividends (expecting the stock price to trade flat or decline) and was surprised to find the stock up 25%. Do you think I should realize the capital gain, hold hoping for a bigger capital gain down the road (couple months maybe) or maintain my original strategy of holding for the dividends? If the recommendation is to sell do you have any recommendations of safe dividend paying stocks to put the money into?
Q: I have noticed the stock price has been steadily rising, very abnormal activity for this stock. Yet ... no news. Can you see any reasons for this, such as volume levels, etc.? Please speculate as to any reasons that are likely at all. Thanks! PK
Q: Can you please comment on how BCE is progressing with its long term goals.
Also, can you please compare its EBITDA for 2023 to its past history. Are things getting better or worse ? Thank you very much
Q: I know it's tricky to evaluate a potential pharma cancer treatment equity but what do you think about this one? It looks like they'll need to dilute massively soon which likely explains my current ~80% paper loss. It's in my TFSA (stupid move on my part as it turns out). Time to take my hit and move on or hope for a miracle?
Q: Can you please provide Market Cap for each of these 3. The Cap when they started on the market and what the current Market Cap is as of today. Just trying to get one version that it is accurate. P.S. Thank you for calling this group out.
Q: Hi 5i Team - Could you provide an update on Intellia, its balance sheet including cash on hand for R&D and day-to-day expenses, as well as insider holdings. Could you also comment on its potential over the next couple of years including info on its third stage trials for new technology which targets mutated genes. It was a top pick on today's (Monday's) Market Call. Thanks.
Q: I own Shockwave, which popped following the news that they’re in talks with Johnson & Johnson to be acquired. I know Boston Scientific showed interest last year. There’s no offer yet and I’m not sure of the best course of action at this point. Is it realistic for the stock price to keep climbing? Any general guidance?
The Canadian banking sector has been fairly muted for a while now, notwithstanding higher rates which have been beneficial in boosting interest income. And, soon, rates are expected to decrease. Is that going to hurt their earnings or help due to an overall smaller delinquency in loan repayments? If it will help, from a choice of buying and holding some of the smaller Canadian on-line only banks or the traditional ones, say for the next five years, which would you recommend?
Can you take a look at TMC and give me your assessment of fundimentals and explain their business activity?
I see from the charts they went public 9/21ish. Had a geat few early days of trading, 10-15 dollar range, before immediate retracement back to 10 before month end. From that point, it's been a steady decline trading in a 2-4 dollar range to date.
Some good trades along the way, but early investors are now left holding this bag. Seen this movie before couple of times.
Q: Can you comment on the earnings release and outlook going forward. Does this one earnings release change your most recent opinions on the company or are your recent opinions remaining status quo for now?
p.s. how do we find out how many credits do we have left before subscription renewal?